Abstract:<p>Fluorescence imaging in the second near‐infrared region (NIR‐II) can penetrate tissue at centimeter depths and obtain high image fidelity. However, facile synthesis of small‐molecule fluorescent photosensitizers for efficient NIR‐II fluorescence imaging as well as photodynamic and photothermal combinatorial therapies is still a challenging task. Herein, a rational design and facile synthesis protocol are reported for a series of novel NIR‐emissive zwitterionic luminogens with aggregation‐induced emission (AIE) features for cancer phototheranostics. Consistent with the intrinsic features including long emission wavelength, effective reactive oxygen species generation, and excellent photothermal conversion efficiency (35.76%), in vitro and in vivo evaluation show that one of these presented AIE luminogens provides excellent performance in NIR‐II fluorescence imaging‐guided synergistic phototherapy against cancer.</p>

What problem does this paper attempt to address?

This paper attempts to solve the following problems: 1. **Develop efficient NIR - II fluorescence imaging probes**: Currently, the synthesis of small - molecule fluorescent photosensitizers for near - infrared two - region (NIR - II, 1000 - 1700 nm) fluorescence imaging is relatively complex and not very efficient. In this paper, a series of new zwitterionic aggregation - induced emission (AIE) molecules are rationally designed and simply synthesized to achieve efficient NIR - II fluorescence imaging. 2. **Enhance the synergistic therapeutic effect of photodynamics and photothermal**: The application of traditional photodynamic therapy (PDT) and photothermal therapy (PTT) in cancer treatment is limited by the performance of photosensitizers. This paper aims to develop an AIE molecule with high reactive oxygen species (ROS) generation ability and excellent photothermal conversion efficiency (35.76%) for the synergistic phototherapy of cancer. 3. **Simplify the synthesis steps and improve biocompatibility**: Reported AIE molecules usually require multi - step reactions and cumbersome purification processes, which limit their practical applications. In addition, most NIR - II AIE molecules adopt specific electron - donor - acceptor structures, and the molecular diversity is insufficient. This paper proposes a simple synthesis method and improves the biocompatibility and low toxicity of the molecules by introducing a zwitterionic structure. ### Core objectives of the paper The core objective of the paper is to design and synthesize a new type of AIE molecule (BITT), which has the following characteristics: - **Long - wave emission**: It can perform efficient fluorescence imaging in the NIR - II region. - **High ROS generation ability**: It is used for photodynamic therapy. - **Excellent photothermal conversion efficiency**: It is used for photothermal therapy. - **Good biocompatibility**: Ensure that there is no obvious toxicity to normal tissues in in - vivo experiments. Through these characteristics, BITT can be used as a single - component diagnosis and treatment probe to realize the cancer synergistic phototherapy guided by NIR - II fluorescence imaging. ### Key points of the solution 1. **Molecular design**: By combining strong electron - donor and - acceptor units and expanding the π - conjugated system, an AIE molecule with a twisted molecular structure is designed. 2. **Synthesis method**: The Suzuki - Miyaura coupling reaction and the Knoevenagel condensation reaction are used to achieve simple and efficient molecular synthesis. 3. **Performance verification**: Through in - vitro and in - vivo experiments, the superior performance of BITT in NIR - II fluorescence imaging, ROS generation, photothermal conversion and anti - cancer effects is verified. Finally, the paper provides a promising strategy for designing efficient NIR AIE molecules and opens up a new path for the efficient treatment of cancer.

Zwitterionic AIEgens: Rational Molecular Design for NIR‐II Fluorescence Imaging‐Guided Synergistic Phototherapy

NIR-II emissive multifunctional AIEgen with single laser-activated synergistic photodynamic/photothermal therapy of cancers and pathogens

Add the Finishing Touch: Molecular Engineering of Conjugated Small Molecule for High‐Performance AIE Luminogen in Multimodal Phototheranostics

Designing NIR AIEgens for lysosomes targeting and efficient photodynamic therapy of tumors

Utilizing a Pyrazine-Containing Aggregation-Induced Emission Luminogen As an Efficient Photosensitizer for Imaging-Guided Two-Photon Photodynamic Therapy.

Theoretical Insights into Rational Design of Small Organic Phototheranostic Agents for Promoting Image-Guided Cancer Surgery

Dual-modal Imaging-Guided Agent Based on NIR-II Aggregation-Induced Emission Luminogens with Balanced Phototheranostic Performance

Molecular Engineering of Near‐Infrared‐II Photosensitizers with Steric‐Hindrance Effect for Image‐Guided Cancer Photodynamic Therapy

Polycyclic naphthalenediimide-based nanoparticles for NIR-II fluorescence imaging guided phototherapy

Molecular Engineering of High-Performance Aggregation-Induced Emission Photosensitizers to Boost Cancer Theranostics Mediated by Acid-Triggered Nucleus-Targeted Nanovectors

Near‐Infrared II AIE Luminogens with Mitochondria‐Targeting Characteristics for Combinational Phototherapies of Breast Tumors Through Synergistic Cell Apoptosis and Pyroptosis

Rational Design of NIR-II AIEgens with Ultrahigh Quantum Yields for Photo- and Chemiluminescence Imaging

Bright Near-Infrared Aggregation-Induced Emission Luminogens with Strong Two-Photon Absorption, Excellent Organelle Specificity, and Efficient Photodynamic Therapy Potential

Aggregation‐Induced Emission Nanoprobes Working in the NIR‐II Region: From Material Design to Fluorescence Imaging and Phototherapy

Optimizing Comprehensive Performance of Aggregation‐Induced Emission Nanoparticles through Molecular Packing Modulation for Multimodal Image‐Guided Synergistic Phototherapy

Enhancing near-infrared AIE of photosensitizer with twisted intramolecular charge transfer characteristics via rotor effect for AIE imaging-guided photodynamic ablation of cancer cells

Rational Design of Conjugated Small Molecules for Superior Photothermal Theranostics in the NIR‐II Biowindow

As Aggregation‐Induced Emission Meets with Noncovalent Conformational Locks: Subtly Regulating NIR‐II Molecules for Multimodal Imaging‐Navigated Synergistic Therapies

Molecular Engineering of an Organic NIR-II Fluorophore with Aggregation-Induced Emission Characteristics for In Vivo Imaging.

Aggregation‐Induced Emission Near‐Infrared (NIR)‐II‐Conjugated Polymers Coupled With Nonconjugated Segments for NIR‐II Fluorescence Imaging–Guided NIR‐II Photothermal Therapy